Form 4 for IONS IONIS PHARMACEUTICALS INC
Accepted 2026-07-09 18:07:45 ET · period of report 2026-07-07 · accession 0000874015-26-000236 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| T | 2026-07-09 18:07 | 2026-07-07 | IONS | Kordasiewicz Holly B. | EVP, Chief Development Off | S - Sale | $84.30 | -362 | 22.1K | -2% | -$30.5K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-07-07 | S | D | 362 | $84.30 | 22,096 | D | — | — | (F1) Shares sold pursuant to a Rule 10b5-1 Trading Plan adopted by the reporting person on March 13, 2026 |